Dr. Eugene James Burchell Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1500 James Simpson Jr Way, Would Care Dept., Covington, KY 41011 Phone: 859-655-1100 Fax: 859-655-1102 |
Beth Ann Myers, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1401 Madison Ave, Covington, KY 41011 Phone: 859-655-6100 Fax: 859-655-6148 |
Alpha A Seales, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 806 Scott St, Covington, KY 41011 Phone: 859-491-6411 Fax: 859-491-6450 |
Marihelen Dooley, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1401 Madison Ave, Covington, KY 41011 Phone: 859-655-6100 Fax: 859-655-6148 |
News Archive
A new study from researchers at the UCLA Jonsson Comprehensive Cancer Center helps explain how disruptions in genes can lead to the resistance to one of the leading immunotherapies, PD-1 blockade, and how new drug combinations could help overcome resistance to the anti-PD-1 therapy in a mechanistically-based way.
Tendon injuries, especially those acquired while engaging in sports, are not easily healed due to the fibrous nature of tendon tissues which transmit forces from muscle to bone and protect surrounding tissues against tension and compression. Tendon injuries to wrists, knees, elbows and rotator cuffs, often from over use when playing golf or tennis, are increasingly common for both professional and amateur athletes ("weekend warriors") alike.
On January 8, 2010, CHUM neurosurgeon Dr. Alain Bouthillier will leave for Argentina, where he will brave the 6,962-metre heights (over 22,840 feet) of Mount Aconcagua. Dr. Bouthillier's climb is intended to raise public awareness about epilepsy and raise funds for further research on the illness.
University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases - thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation.
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
› Verified 9 days ago